Cited by 177Pulmonary Hypertension Research and TreatmentsNitric Oxide and Endothelin EffectsTGF-β signaling in diseases

NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-β1 and insulin-like growth factor binding protein-3

Open access
Ismail, Saleh, Sturrock, Anne, Wu, Ping, Cahill, Barbara, Norman, Kimberly, Huecksteadt, Thomas, Sanders, Karl, Kennedy, Thomas +1 more·2009·American Journal of Physiology-Lung Cellular and Molecular Physiology

Abstract

Persistent hypoxia can cause pulmonary arterial hypertension that may be associated with significant remodeling of the pulmonary arteries, including smooth muscle cell proliferation and hypertrophy. We previously demonstrated that the NADPH oxidase homolog NOX4 mediates human pulmonary artery smooth muscle cell (HPASMC) proliferation by transforming growth factor-β1 (TGF-β1). We now show that hypoxia increases HPASMC proliferation in vitro, accompanied by increased reactive oxygen species generation and NOX4 gene expression, and is inhibited by antioxidants, the flavoenzyme inhibitor diphenyleneiodonium (DPI), and NOX4 gene silencing. HPASMC proliferation and NOX4 expression are also observed when media from hypoxic HPASMC are added to HPASMC grown in normoxic conditions, suggesting autocrine stimulation. TGF-β1 and insulin-like growth factor binding protein-3 (IGFBP-3) are both increased in the media of hypoxic HPASMC, and increased IGFBP-3 gene expression is noted in hypoxic HPASMC. Treatment with anti-TGF-β1 antibody attenuates NOX4 and IGFBP-3 gene expression, accumulation of IGFBP-3 protein in media, and proliferation. Inhibition of IGFBP-3 expression with small interfering RNA (siRNA) decreases NOX4 gene expression and hypoxic proliferation. Conversely, NOX4 silencing does not decrease hypoxic IGFBP-3 gene expression or secreted protein. Smad inhibition does not but the phosphatidylinositol 3-kinase (PI3K) signaling pathway inhibitor LY-294002 does inhibit NOX4 and IGFBP-3 gene expression, IGFBP-3 secretion, and cellular proliferation resulting from hypoxia. Immunoblots from hypoxic HPASMC reveal increased TGF-β1-mediated phosphorylation of the serine/threonine kinase (Akt), consistent with hypoxia-induced activation of PI3K/Akt signaling pathways to promote proliferation. We conclude that hypoxic HPASMC produce TGF-β1 that acts in an autocrine fashion to induce IGFBP-3 through PI3K/Akt. IGFBP-3 increases NOX4 gene expression, resulting in HPASMC proliferation. These observations add to our understanding hypoxic pulmonary vascular remodeling.

Integrity signals

Registry

Crossref · 10.1152/ajplung.90488.2008

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ismail, S., Sturrock, A., Wu, P., Cahill, B., Norman, K., Huecksteadt, T., Sanders, K., Kennedy, T., & Hoidal, J.
Affiliations
University of Utah (US)
Venue
American Journal of Physiology-Lung Cellular and Molecular Physiology
Published
2009-03
Volume
296
Issue
3
Pages
L489-L499
ISSN
  • 1040-0605 (ISSN-L)
  • 1522-1504
OpenAlex
W2141997908
Cited by
177
References
73
Citations by year
2026: 2 · 2025: 4 · 2024: 4 · 2023: 3 · 2022: 5 · 2021: 7 · 2020: 3 · 2019: 12 · 2018: 11 · 2017: 14 · 2016: 14 · 2015: 16 · 2014: 13 · 2013: 17 · 2012: 21
FWCI
9.52
Type
journal article
Language
en
Open access
Locations
  • American Journal of Physiology-Lung Cellular and Molecular Physiology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (R01HL067281, HL67281)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
NOX4, pulmonary artery smooth muscle cells, hypoxia, cell proliferation, pulmonary arterial hypertension, autocrine signaling, TGF-β1, insulin-like growth factor binding protein-3, NADPH oxidase, reactive oxygen species, PI3K/Akt signaling, Smad signaling, pulmonary vascular remodeling, diphenyleneiodonium
MeSH terms
NADPH Oxidase 4, Cells, Cultured, Humans, Models, Biological, Pulmonary Artery, Signal Transduction, Cell Hypoxia, Gene Expression, Reactive Oxygen Species, Insulin-Like Growth Factor Binding Proteins, Insulin-Like Growth Factor Binding Protein 3, NADPH Oxidases, Phosphatidylinositol 3-Kinases, Autocrine Communication, Myocytes, Smooth Muscle, RNA Interference, Cell Proliferation, Proto-Oncogene Proteins c-akt, Transforming Growth Factor beta1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review